Browse resources

Topic: Immunization financing

Total results with these characteristics: 124

Page 3 of 5  
‹ prev.
1
2
3
4
5
next ›

Global Polio Eradication Initiative: Strategic Plan 2010-2012

Alarmed that polio remained entrenched in the four countries that had never stopped transmission, and that an increasing number of polio-free areas were becoming reinfected, in May 2008 the World Health Assembly called for a new strategy to complete …

Author: World Health Organization

Published: 2010

Global Post-Eradication IPV Supply and Demand Assessment: Integrated Findings

This report summarizes the findings from a global post-eradication inactivated polio vaccine (IPV) supply and demand assessment conducted from 2007 to 2008. The goal of the study was to inform ongoing IPV discussions and potential policy development …

Author: Oliver Wyman, Inc.

Published: 2009

Global Vaccine Action Plan 2011-2020

The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World Health Assembly in May 2012—is a roadmap to prevent millions of deaths by 2020 through more equitable access to vaccines for people in all communities. …

Author: World Health Organization

Published: 2012

Global Vaccine Action Plan: Strategic Advisory Group of Experts on Immunization: Assessment Report 2013

The Global Vaccine Action Plan (GVAP) was endorsed by the World Health Assembly in May 2012 to achieve its “Decade of Vaccines” vision of universal access to immunization. As requested by the Member States, the World Health Organization's …

Author: World Health Organization

Published: 2013

Going for Goal: Immunisation and the Case for GAVI

Like the World Cup—with teams from six continents coming together to compete on a level playing field—the GAVI Alliance is also a story about the world coming together: different donors, countries, activists, technical partners, and private …

Author: The ONE Campaign

Published: 2014

Guidelines for Estimating the Economic Burden of Diarrheal Disease with Focus on Assessing the Costs of Rotavirus Diarrhea

WHO developed these guidelines to present a method for determining the costs associated with diarrheal disease in children under 5 years of age.

Author: World Health Organization

Published: 2002

Health Care Costs of Diarrheal Disease and Estimates of the Cost-Effectiveness of Rotavirus Vaccination in Vietnam

This study, published in The Journal of Infectious Diseases, estimated economic burden and the vaccination cost-effectiveness ratio to determine potential reductions in health care costs associated with rotavirus-specific diarrhea.

Author: Fischer T, Anh D, Antil L, et al.

Published: 2005

Health Economics of Rotavirus Immunization in Vietnam: Potentials for Favorable Cost-Effectiveness in Developing Countries

This article, published in Vaccine, reports on a study designed to assess the cost-effectiveness of rotavirus immunization in Vietnam. It specifically focused on the use of RotaTeq® and assessing the affordability of implementing universal …

Author: Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ

Published: 2012

Hexavalent IPV-Based Combination Vaccines for Public-Sector Markets of Low-Resource Countries

This article, published in Human Vaccines & Immunotherapeutics, evaluates potential hexavalent vaccine candidates containing inactivated polio vaccine (IPV) that could provide reliable, low-cost, and continuous immunization to sustain polio …

Author: Mahmood K, Pelkowski S, Atherly D, Sitrin R, Donnelly JJ

Published: 2013

HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues

This report addresses issues related to financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms, which will constitute some of the most significant challenges to achieving widespread HPV …

Author: International AIDS Vaccine Initiative, PATH

Published: 2007

HPV Vaccines and Screening in the Prevention of Cervical Cancer

This monograph, published in Vaccine, summarizes the present state of human papillomavirus vaccines and screening in the prevention of cervical cancer. It provides a number of articles covering epidemiological achievements, technical developments, …

Author: Bosch FX, Cuzick J, Schiller JT, et al., eds.

Published: 2006

Immunization Financing Options: A Resource for Policymakers

These user-friendly briefing sheets, prepared by the World Bank and intended for policymakers in Ministries of Health, Finance, Planning and Investment, outline options for financing national immunization services.

Author: GAVI Alliance

Published: 2002

Immunization Financing Through the GAVI Alliance

An overview of immunization support to developing countries provided through the GAVI Alliance.

Author: World Health Organization

Published: 2006

Immunization Financing Toolkit: A Resource for Policy-­Makers and Program Managers

Financing is a critical component of a sustainable immunization program. This toolkit is comprised of a series of short briefs on different options for financing national immunization programs and vaccines. It is intended to serve as a resource for …

Author: World Bank, GAVI Alliance

Published: 2010

Immunization Planning and Financing

This web page is an online resource for information and data about immunization financing in low- and lower-middle-income countries. It country profiles with a summary of the immunization financing situation, key data, and indicators of …

Author: World Health Organization

Improving Global Health by Preventing Pneumococcal Disease

This report summarizes the results of a six-month inquiry by the UK All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World (APPG) on the global disease burden of pneumococcal disease and pneumonia, …

Author: UK All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World

Published: 2008

Improving the Affordability of Inactivated Poliovirus Vaccines (IPV) for Use in Low- and Middle-Income Countries: An Economic Analysis of Strategies to Reduce the Cost of Routine IPV Immunization

This report presents results from an economic model that calculates the costs involved in delivering IPV vaccine in Indian immunization clinics according to three strategies: (1) intradermal delivery of reduced volumes of vaccine per dose, (2) use …

Author: PATH, Working in Tandem, Ltd.

Published: 2010

Incentives and Innovative Financing for Global Health Product Development

This fact sheet explores different incentives and innovative financing mechanisms and their role in the development of global health products, including vaccines. In addition to providing an overview of the different options available, it also …

Author: Global Health Technologies Coalition

Published: 2010

Incremental Costs of Introducing Jet Injection Technology for Delivery of Routine Childhood Vaccinations: Comparative Analysis From Brazil, India, and South Africa

This article, published in Vaccine, describes a study that estimated the incremental costs of transitioning from needles and syringes to delivering childhood vaccines with disposable-syringe jet injectors (DSJIs) in Brazil, India, and South Africa. …

Author: Griffiths UK, Santos AC, Nundy N, Jacoby E, Matthias D

Published: 2011

The International Finance Facility for Immunization (IFFIm)

General information on the function and objectives of IFFIm, a new funding mechanism that secures pledges of future aid in order to leverage money from international capital markets to support national immunization programmes.

Author: World Health Organization

Published: 2006

An Introduction to the Global Immunization Vision and Strategy

This brochure describes the Global Immunization Vision and Strategy (GIVS), which aims to protect more people against more diseases. It describes achievements in childhood immunization and the benefits of this key and cost-effective health …

Author: World Health Organization, United Nations Children's Fund

Published: 2009

Investing in Vaccines for the Developing World

This fact sheet on investing in vaccines for the developing world details the cost of developing and distributing vaccines, and it outlines the innovative funding solutions designed to address these issues.

Author: PATH

Published: 2013

Investing Together for a Healthy Future: The 2016-2020 GAVI Alliance Investment Opportunity

This report makes the case for the GAVI Alliance's call for an additional investment of US$7.5 billion to help immunize an additional 300 million children from 2016 to 2020. It includes GAVI's plan for increasing the proportion of children worldwide …

Author: GAVI Alliance

Published: 2014

IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening

This web page contains the rationale for and resources related to the introduction of inactivated polio vaccine (IPV), withdrawal of oral polio vaccine (OPV), and routine immunization strengthening. It provides five in-depth modules covering issues …

Author: World Health Organization

Is the Pneumococcal Vaccine Advance Market Commitment Motivating Innovation and Increasing Manufacturing Capacity? Some Preliminary Answers

This article, published in Vaccine, provides preliminary evidence on the potential outcome of the pneumococcal vaccine Advance Market Commitment, with a focus on its impact on innovation in emerging vaccine manufacturers in low-resource countries. …

Author: Plahte J

Published: 2012

Page 3 of 5  
‹ prev.
1
2
3
4
5
next ›